CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-21 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −4 | $146.85 | $587 | 141,486 |
| 2025-04-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −464 | $145.54 | $68K | 225,673 |
| 2025-04-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −6 | $146.16 | $877 | 225,667 |
| 2025-04-21 | Sheena Jonathan Director | Sale 10b5-1 | −85 | $145.54 | $12K | 255,354 |
| 2025-04-21 | Sheena Jonathan Director | Sale 10b5-1 | −1 | $146.16 | $146 | 255,353 |
| 2025-04-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,521 | 77,078 | ||
| 2025-04-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −1,521 | 4,566 | ||
| 2025-04-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +3,386 | 200,029 | ||
| 2025-04-20 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Restricted Stock Unit 10b5-1 | −3,386 | 10,158 | ||
| 2025-04-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +856 | 226,137 | ||
| 2025-04-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −856 | 2,568 | ||
| 2025-04-20 | Sheena Jonathan Director | Option exercise 10b5-1 | +190 | 255,439 | ||
| 2025-04-20 | Sheena Jonathan Director | Option exercise · Restricted Stock Unit 10b5-1 | −190 | 571 | ||
| 2025-04-04 | Sheena Jonathan Director | Sale 10b5-1 | −1,220 | $132.04 | $161K | 257,099 |
| 2025-04-04 | Sheena Jonathan Director | Sale 10b5-1 | −1,050 | $133.28 | $140K | 256,049 |
| 2025-04-04 | Sheena Jonathan Director | Sale 10b5-1 | −400 | $133.86 | $54K | 255,649 |
| 2025-04-04 | Sheena Jonathan Director | Sale 10b5-1 | −300 | $135.24 | $41K | 255,349 |
| 2025-04-04 | Sheena Jonathan Director | Sale 10b5-1 | −100 | $136.05 | $14K | 255,249 |
| 2025-04-03 | Sheena Jonathan Director | Sale 10b5-1 | −240 | $136.99 | $33K | 41,542 |
| 2025-04-03 | Sheena Jonathan Director | Sale 10b5-1 | −477 | $138.57 | $66K | 41,065 |
Page 49 of 55 · 1,093 trades